Which conditions cause painful, pruritic skin eruptions triggered by sunlight and may be associated with elevated C-reactive protein?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Photodermatoses: Polymorphic Light Eruption, Chronic Actinic Dermatitis, and Solar Urticaria

The primary conditions causing painful, pruritic skin eruptions triggered by sunlight are Polymorphic Light Eruption (PLE), Chronic Actinic Dermatitis (CAD), and Solar Urticaria (SU), with elevated CRP most commonly associated with Sweet syndrome when photoinduced, though CRP elevation can also occur in chronic spontaneous urticaria variants. 1, 2, 3

Primary Photodermatoses to Consider

Polymorphic Light Eruption (PLE)

  • Most common photodermatosis affecting primarily fair-skinned individuals (Fitzpatrick types I-IV) 4
  • Presents as pruritic, erythematous papules, plaques, or vesicles on sun-exposed areas
  • Develops 30 minutes to several hours after sun exposure
  • Eruption persists from hours to 2 weeks
  • Females affected 2-3 times more than males
  • Pruritus reported in 18-33% of patients during phototherapy treatment 1
  • Represents an immune-mediated delayed-type hypersensitivity reaction 4

Chronic Actinic Dermatitis (CAD)

  • Requires close supervision during phototherapy with topical or systemic corticosteroid coverage 1
  • More severe photodermatosis requiring maintenance treatment
  • Associated with significant inflammatory response

Solar Urticaria (SU)

  • Urticarial lesions develop immediately to hours after sunlight exposure
  • Can be associated with elevated inflammatory markers 3, 5
  • Treatment carries risk of provocation, syncope, and anaphylaxis 1
  • Requires determination of action spectrum via specialized phototesting before treatment 1
  • Standard therapy includes high-dose H1 antihistamines 1

Conditions with Elevated CRP

Photo-Induced Sweet Syndrome

This is the most specific condition linking painful, pruritic sun-induced eruptions with elevated CRP 2

Key features:

  • Painful, mildly pruritic rash on sun-exposed areas (neck, arms, legs)
  • Accompanied by systemic symptoms: fever, chills, malaise, nausea
  • Laboratory findings: leukocytosis with absolute neutrophilia, elevated CRP, elevated ESR 2
  • Skin biopsy shows papillary dermal edema with dense neutrophilic infiltration
  • Responds dramatically to systemic steroids
  • Underlying mechanism remains unknown but excessive sunlight exposure is a recognized trigger 2

Chronic Spontaneous Urticaria (CSU) with Photosensitivity

  • One-third of CSU patients have elevated CRP levels 3
  • Higher CRP correlates with:
    • Greater urticaria activity (P < .001)
    • Quality of life impairment (P = .026)
    • Poor response to antihistamines (P < .001) 3
  • CRP levels significantly higher in antihistamine nonresponders 3

Leukocytoclastic Vasculitis (Rare Variant)

  • Urticarial lesions developing hours after sunlight exposure
  • Resolves after approximately 1 week
  • Histology shows leukocytoclastic vasculitis rather than typical urticaria 5
  • Can present with elevated inflammatory markers

Diagnostic Algorithm

When evaluating painful, pruritic, sun-induced eruptions with elevated CRP:

  1. Timing of onset post-exposure:

    • Immediate to minutes: Solar urticaria
    • 30 minutes to hours: PLE or photo-induced Sweet syndrome
    • Hours: Leukocytoclastic vasculitis variant
  2. Systemic symptoms present:

    • Fever, chills, malaise → Sweet syndrome most likely 2
    • No systemic symptoms → PLE, CAD, or SU
  3. Laboratory evaluation:

    • CBC with differential (neutrophilia suggests Sweet syndrome)
    • CRP and ESR (both elevated in Sweet syndrome) 2
    • Consider D-dimer, fibrinogen if vasculitis suspected 3
  4. Skin biopsy findings:

    • Dense neutrophilic infiltration → Sweet syndrome 2
    • Leukocytoclastic vasculitis → Rare solar urticaria variant 5
    • Delayed-type hypersensitivity pattern → PLE 4
  5. Duration of lesions:

    • Hours to days: Solar urticaria
    • Days to 2 weeks: PLE
    • ~1 week: Leukocytoclastic vasculitis variant 5

Critical Clinical Pitfalls

Do not assume all photosensitive eruptions are benign photodermatoses. Photo-induced Sweet syndrome requires systemic corticosteroids and evaluation for underlying malignancy, infection, or medication triggers 2. The presence of elevated CRP with systemic symptoms distinguishes this from typical PLE or solar urticaria.

Elevated CRP in urticarial conditions predicts poor antihistamine response 3, so these patients may require earlier escalation to omalizumab or other advanced therapies rather than prolonged trials of antihistamines.

Phototherapy for photodermatoses carries significant provocation risk (12-50% for PLE during PUVA courses) 1, requiring careful dose escalation and consideration of prophylactic topical or systemic corticosteroids 1.

The association between lupus erythematosus and photosensitivity should be considered, though solar urticaria and EPP associations with lupus appear coincidental 6. However, drug-induced photosensitivity from medications like thiazides, neuroleptics, and tetracyclines can complicate the clinical picture 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.